Use of corticosteroids to suppress drug toxicity in complicated tuberculosis

Journal of Infection

Volumn 39, Issue 3, 1999, Pages 237-240

  Morris, Huw ^a   Muckerjee, Jay ^a   Akhtar, Shadaba ^b   Abdullahi, Leyla ^a   Harrison, Michael ^a   Scott, Geoffrey ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; HUMAN; LIVER DYSFUNCTION; MALE; PRURITUS; SKIN MANIFESTATION; TUBERCULOSIS; VOMITING;

EID: 0033383675     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90057-9     Document Type: Article

References (17)

1. Strang JI, Kakasa HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis. Lancet 1987; ii: 1418-1422.
2. Kumarvelu S, Prasad K, Khosla A, Behari M. Ahuja GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tab Lung Dis 1994; 75: 203-207
3. Grewal KS, Dixit RP. Sil DR. A comparative study of therapeutic regimens with and without corticosteroids in the treatment of tuberculous pleural effusion. J Ind Med Ass 1969; 52: 514-516
4. Senderovitz T, Viskum K. Corticosteroids and tuberculosis. Resp Med 1994; 88: 561-565
5. Elansery EH, Earis JE. Rifampicin and adrenal crisis. Br Med J 1983; 286: 1861-1862
6. Horne NW. Prednisolone in treatment of pulmonary tuberculosis: a controlled trial. Br Med J 1960; ii: 1751-1756
7. Jenkins PF, Williams TD. Campbell IA. Neutropenia with each standard antituberculosis drug in the same patient. Br Med J 1980; 280: 1069-1070
8. Chung KF, Snashall PD. Suppression of prolonged fever during treatment for pulmonary tuberculosis: importance of using twice versus single daily dose of prednisolone. Postgrad Med J 1983; 59: 373-375
9. Teoh R, Humphries M. Tuberculous Meningitis. In: Lambert HP, ed. Infections of the Central Nervous System Edward Arnold, 1991: 189-206
10. Horne NW, Tulloch WS. Conservative management of renal tuberculosis. Br J Urol 1975; 47: 481-487
11. Onwubalili JK, Scott GM. Immune status in tuberculosis and response to treatment. Tubercle 1988; 69: 81-94
12. Ellis ME and Webb AK. Cause of death in patients admitted to hospital for pulmonary tuberculosis. Lancet 1983; i: 665-667
13. Humphries MJ, Byfield SP, Darbyshire JH et al. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest 1984; 78: 149-158
14. Scott GM, Murphy PG, Gemidjioglu E. Predicting deterioration of treated tuberculosis by corticosteroid reserve and C-reactive protein. J Infect 1990; 21: 61-69
15. Buchanan G, Rainer EH. Tuberculous mastoiditis. J Layngol Otol 1988; 102: 440-446
16. Ramages LJ, Gertler R. Aural tuberculosis: a series of 25 patients. J Laryngol Otol 1985; 99: 1073-1080
17. Thomson JE. The management of hypersensitivity reactions to antituberculous drugs. Med J Aust 1969; 2: 1058-1063